Logo-jcvtr

J Cardiovasc Thorac Res. 2021;13(2): 131-140. doi: 10.34172/jcvtr.2021.27
PMID: 34326967        PMCID: PMC8302894

Original Article

Resveratrol reduced the detrimental effects of malondialdehyde on human endothelial cells

Mehdi Hassanpour 1,2 ORCID, Çıgır Biray Avci 3 ORCID, Reza Rahbarghazi 1,4 * ORCID, Aysa Rezabakhsh 5 ORCID, Alireza Nourazarian 2 ORCID, Elahe Nabat 1, Farzaneh Fathi 6 ORCID, Majid Khaksar 1

Cited by CrossRef: 2


1- Gaggini M, Fenizia S, Vassalle C. Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease. Antioxidants. 2023;12(5):1102 [Crossref]
2- Zhang S, Kiarasi F. Therapeutic effects of resveratrol on epigenetic mechanisms in age‐related diseases: A comprehensive review. Phytotherapy Research. 2024;38(5):2347 [Crossref]
3- Modzelewska B, Drygalski K, Hady H, Kiełczewska A, Chomentowski A, Koryciński K, Głuszyńska P, Kleszczewski T. Resveratrol Relaxes Human Gastric Smooth Muscles Through High Conductance Calcium-Activated Potassium Channel in a Nitric Oxide-independent Manner. Front Pharmacol. 2022;13 [Crossref]
4- Jin S, Kang P. A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases. Antioxidants. 2024;13(8):923 [Crossref]
5- Elsayed Abouzed D, Ezelarab H, Selim H, Elsayed M, El Hamd M, Aboelez M. Multimodal modulation of hepatic ischemia/reperfusion-induced injury by phytochemical agents: A mechanistic evaluation of hepatoprotective potential and safety profiles. International Immunopharmacology. 2024;138:112445 [Crossref]